Skip to main content
. 2013 Dec 15;1(7):e00184. doi: 10.1002/phy2.184

Table 1.

Changes in RV with 14‐, 21‐, and 28‐HySu compared to Normoxia

Group Normoxia 14‐HySu 21‐HySu 28‐HySu
RVSP 26 ± 1 37 ± 2* 41 ± 2* 45 ± 1*
RVEDP 0.8 ± 0.1 1.2 ± 0.1 1.4 ± 0.1* 1.4 ± 0.2*
LV+S 78.3 ± 2.2 77.8 ± 4.3 79.5 ± 2.6 78.9 ± 4.5
BW 25.3 ± 0.6 23.2 ± 0.4 23.2 ± 0.9 24.1 ± 0.6
Fulton index 0.26 ± 0.01 0.40 ± 0.02* 0.43 ± 0.01* 0.44 ± 0.03*
Hct 46 ± 1.1 75 ± 2.2* 74 ± 1.2* 61 ± 0.4*
RV compliance 0.53 ± 0.03 0.36 ± 0.04* 0.36 ± 0.03* 0.30 ± 0.01*
τ 5.7 ± 0.5 3.1 ± 0.6* 4.9 ± 0.4 5.0 ± 0.3
EDV 23.8 ± 1.0 26.4 ± 3.1 28.9 ± 2.2 29.9 ± 1.5
ESV 9.8 ± 0.6 12.4 ± 2.6 14.8 ± 1.9 16.5 ± 1.3
SV 14.7 ± 1.0 14.9 ± 1.4 14.2 ± 1.0 13.4 ± 0.7
HR 552 ± 16 597 ± 17 591 ± 19 597 ± 17
Aortic pressure 53 ± 5 55 ± 3 59 ± 1 55 ± 1

N = 8–9 per group. RVSP (mmHg), RV end‐diastolic pressure (RVEDP, mmHg), LV + Septum mass (LV+S, mg), body weight (BW, g), Fulton index (mg/mg), hematocrit (Hct,%), RV compliance (μL/mmHg), relaxation factor τ (msec), end‐diastolic volume (EDV, μL), end‐systolic volume (ESV, μL), stroke volume (SV, μL), heart rate (HR, beats/min), aortic pressure (mmHg).

*

P < 0.05 versus Normoxia.